Who owns Milestone Pharmaceuticals Inc?
- Ticker: MIST
- CUSIP Number: 59935v107
Tip: Access positions for across all investors
Analyze quarterly positions in Milestone Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Milestone Pharmaceuticals stock
Who bought or sold Milestone Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 5.0M | $7.6M | 100% | Sep 2024 |
|
| BlackRock | 5.0M | $6.6M | 0% | Jun 2024 |
|
| Lion Point Capital | 2.3M | $3.1M | 2% | Jun 2024 |
|
| Citadel Advisors | 2.1M | $3.1M | -5% | Sep 2024 |
|
| OrbiMed Advisors | 2.0M | $3.0M | 0% | Sep 2024 |
|
| Nantahala Capital Management | 1.8M | $2.7M | 0% | Sep 2024 |
|
| Goldman Sachs Group | 1.4M | $1.8M | 0% | Jun 2024 |
|
| Bleichroeder | 1.3M | $2.0M | 0% | Sep 2024 |
|
| BML Capital Management | 1.1M | $1.7M | 3% | Sep 2024 |
|
| Altium Capital Management | 1.0M | $1.3M | -17% | Jun 2024 |
|
| Stonepine Capital Management | 1000k | $1.5M | -19% | Sep 2024 |
|
| Morgan Stanley | 829k | $1.1M | 1% | Jun 2024 |
|
| Ikarian Capital | 466k | $708k | 0% | Sep 2024 |
|
| Boxer Capital | 309k | $470k | 0% | Sep 2024 |
|
| Envestnet Asset Management | 71k | $107k | 19% | Sep 2024 |
|
| Ancora Advisors | 60k | $91k | 0% | Sep 2024 |
|
| Squarepoint Ops | 55k | $73k | 100% | Jun 2024 |
|
| Atria Investments | 40k | $61k | 44% | Sep 2024 |
|
| Dimensional Fund Advisors | 40k | $60k | 0% | Sep 2024 |
|
| Pvg Asset Management | 30k | $46k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 29k | $44k | 19% | Sep 2024 |
|
| Northern Trust | 27k | $42k | -3% | Sep 2024 |
|
| Cetera Investment Advisers | 21k | $27k | 19% | Jun 2024 |
|
| Valeo Financial Advisors | 20k | $30k | 100% | Sep 2024 |
|
| Clear Creek Financial Management | 20k | $30k | 0% | Sep 2024 |
|
| State Street Corporation | 19k | $25k | 0% | Jun 2024 |
|
| Geode Capital Management | 18k | $27k | 0% | Sep 2024 |
|
| Beta Wealth | 14k | $22k | 0% | Sep 2024 |
|
| Creative Planning | 13k | $20k | 0% | Sep 2024 |
|
| Engineers Gate Manager | 11k | $17k | 100% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 11k | $16k | 0% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 7.1k | $11k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 6.5k | $9.9k | 8% | Sep 2024 |
|
| Jones Financial Companies, L.L | 1.0k | $1.5k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 800.00 | $1.0k | 100% | Sep 2024 |
|
| Simplex Trading | 214.00 | $0 | -82% | Sep 2024 |
|
| Qube Research & Technologies | 194.00 | $258.000600 | 0% | Jun 2024 |
|
| Oliver Lagore Vanvalin Investment Group | 100.00 | $152.000000 | 0% | Sep 2024 |
|
| Barclays | 100.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Milestone Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 2.7M | $3.7M |
| Susquehanna International | Jun 2024 | 17k | $23k |
| ICA Group Wealth Management | Mar 2024 | 200.00 | $358.000000 |